GLG Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.15M | Buy |
9,602
+7,369
| +330% | +$881K | 0.05% | 272 |
|
|
2017
Q3 | $313K | Sell |
2,233
-10,001
| -82% | -$1.4M | 0.02% | 281 |
|
|
2017
Q2 | $1.49M | Buy |
12,234
+7,567
| +162% | +$921K | 0.08% | 215 |
|
|
2017
Q1 | $566K | Buy |
+4,667
| New | +$566K | 0.03% | 308 |
|
|
2016
Q4 | – | Sell |
-64,341
| Closed | -$7.88M | – | 459 |
|
|
2016
Q3 | $7.88M | Sell |
64,341
-106,420
| -62% | -$13M | 0.24% | 98 |
|
|
2016
Q2 | $19.9M | Sell |
170,761
-89,562
| -34% | -$10.5M | 0.6% | 33 |
|
|
2016
Q1 | $36.2M | Buy |
260,323
+25,313
| +11% | +$3.52M | 1.03% | 9 |
|
|
2015
Q4 | $44.8M | Buy |
235,010
+4,834
| +2% | +$922K | 1.43% | 8 |
|
|
2015
Q3 | $36M | Buy |
230,176
+192,176
| +506% | +$30.1M | 0.95% | 15 |
|
|
2015
Q2 | $6.87M | Buy |
+38,000
| New | +$6.87M | 0.18% | 128 |
|